• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cybin Inc (NY: CYBN )

    0.3000 -0.0090 (-2.91%)
    Official Closing Price Updated: 8:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,506,890
    Open 0.3042
    Bid (Size) 0.2900 (7)
    Ask (Size) 0.2942 (50)
    Prev. Close 0.3090
    Today's Range 0.2929 - 0.3142
    52wk Range 0.2475 - 0.7380
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
    Via AB Newswire
    Exposures Product Safety
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees “Swell” of Insider Investments, Upgrade in Ranking after Positive Year-End Report
    Via Investor Brand Network

    Performance

    YTD
    -25.00%
    -25.00%
    1 Month
    +10.29%
    +10.29%
    3 Month
    -18.90%
    -18.90%
    6 Month
    -16.67%
    -16.67%
    1 Year
    -28.83%
    -28.83%

    More News

    Read More
    Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
    Via InvestorPlace
    CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
    Via InvestorPlace
    3 Psychedelic Stocks to Buy on the Dip: Summer 2024
    Via InvestorPlace
    Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
    Via Benzinga
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases FY Financial Report, Business Update
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
    From Cybin Inc.
    Via Business Wire
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Featured Presenter at Upcoming H.C. Wainwright Neuro Perspectives Virtual Conference
    Via Investor Brand Network
    Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    From Cybin Inc.
    Via Business Wire
    Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar
    Via Investor Brand Network
    Exposures Product Safety
    Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
    From Cybin Inc.
    Via Business Wire
    Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
    Via Benzinga
    Exposures Product Safety
    InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at Interdisciplinary Conference on Psychedelic Research 2024
    Via Investor Brand Network
    Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
    From Cybin Inc.
    Via Business Wire
    BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Slated to Present at Upcoming Alliance Global Partners Healthcare Company Showcase
    Via Investor Brand Network
    Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
    From Cybin Inc.
    Via Business Wire
    Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Issues Corporate Update, Eyes Runway for Upcoming Clinical Milestones
    Via Investor Brand Network
    Exposures Product Safety
    Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
    From Cybin Inc.
    Via Business Wire
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference
    Via Investor Brand Network
    Exposures Product Safety
    Cybin to Participate at the 27th Annual Milken Institute Global Conference
    From Cybin Inc.
    Via Business Wire
    PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Research Published in “Journal of Medicinal Chemistry”
    Via Investor Brand Network
    Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
    From Cybin Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.